Australia OKs Cardiac Science Bedside Device
- Share via
Cardiac Science Inc., an Irvine developer of cardiac defibrillator devices and monitoring software, said Wednesday it has received marketing approval for use of its Powerheart bedside defibrillator-monitor in Australia.
The company said in a press release that it received approval from the Australian Therapeutic Goods Administration.
Cardiac Science also said it sold 50 of the monitors to CS Australia Pty Ltd. for $333,500.
Shares of Cardiac Science, which reported revenue of $102,900 last year, closed Wednesday at $4.38, down 38 cents in Nasdaq trading.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
